Michael L. Chandler

581 total citations
18 papers, 469 citations indexed

About

Michael L. Chandler is a scholar working on Cell Biology, Molecular Biology and Biochemistry. According to data from OpenAlex, Michael L. Chandler has authored 18 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cell Biology, 6 papers in Molecular Biology and 5 papers in Biochemistry. Recurrent topics in Michael L. Chandler's work include Aldose Reductase and Taurine (7 papers), Biochemical Acid Research Studies (4 papers) and Enzyme function and inhibition (3 papers). Michael L. Chandler is often cited by papers focused on Aldose Reductase and Taurine (7 papers), Biochemical Acid Research Studies (4 papers) and Enzyme function and inhibition (3 papers). Michael L. Chandler collaborates with scholars based in United States and China. Michael L. Chandler's co-authors include Partab T. Varandani, Robert R. LeVier, James L. Baker, Mary Ann Nafz, Loretta G. McNatt, Brenda Walker Griffin, Rupali Doshi, Louis DeSantis, Michael A. Kapin and B. Scatton and has published in prestigious journals such as Biochemistry, Diabetes and Plastic & Reconstructive Surgery.

In The Last Decade

Michael L. Chandler

17 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael L. Chandler United States 12 187 177 116 53 51 18 469
G. Hege Thoresen Norway 13 89 0.5× 206 1.2× 33 0.3× 96 1.8× 8 0.2× 21 414
Dorothy Sears Worrall United States 8 107 0.6× 299 1.7× 67 0.6× 165 3.1× 5 0.1× 8 606
Nicole A. Bourbon United States 7 52 0.3× 488 2.8× 106 0.9× 121 2.3× 9 0.2× 7 606
Jung Wha Lee United States 15 355 1.9× 525 3.0× 73 0.6× 36 0.7× 507 9.9× 22 988
Elena Kostromina Russia 8 180 1.0× 223 1.3× 91 0.8× 41 0.8× 4 0.1× 27 450
Ilana Talior Israel 8 80 0.4× 327 1.8× 65 0.6× 156 2.9× 5 0.1× 8 622
Ioanna Daskalaki Greece 8 29 0.2× 462 2.6× 61 0.5× 154 2.9× 13 0.3× 12 726
Rosita Ivarsson Sweden 9 472 2.5× 457 2.6× 207 1.8× 116 2.2× 3 0.1× 9 734
S H Ong United States 13 27 0.1× 194 1.1× 59 0.5× 73 1.4× 3 0.1× 20 371
Tadashi Hanabusa Japan 12 276 1.5× 271 1.5× 87 0.8× 261 4.9× 4 0.1× 20 619

Countries citing papers authored by Michael L. Chandler

Since Specialization
Citations

This map shows the geographic impact of Michael L. Chandler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Chandler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Chandler more than expected).

Fields of papers citing papers by Michael L. Chandler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Chandler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Chandler. The network helps show where Michael L. Chandler may publish in the future.

Co-authorship network of co-authors of Michael L. Chandler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Chandler. A scholar is included among the top collaborators of Michael L. Chandler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Chandler. Michael L. Chandler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mills, Ryan E. & Michael L. Chandler. (2019). MON-353 Vasogenic Cerebral Edema Associated with Radiation-Induced Necrosis Masquerading as Adrenal Insufficiency. Journal of the Endocrine Society. 3(Supplement_1).
2.
Kapin, Michael A., Rupali Doshi, B. Scatton, Louis DeSantis, & Michael L. Chandler. (1999). Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.. PubMed. 40(6). 1177–82. 43 indexed citations
3.
Harwerth, Ronald S., Earl Smith, & Michael L. Chandler. (1999). Progressive Visual Field Defects from Experimental Glaucoma: Measurements with White and Colored Stimuli. Optometry and Vision Science. 76(8). 558–570. 17 indexed citations
4.
Chandler, Michael L., Iok‐Hou Pang, Rupali Doshi, et al.. (1997). In vitro and in vivo protective effects of eliprodil in the retina. Investigative Ophthalmology & Visual Science. 38(4). 2 indexed citations
5.
Robison, W. Gerald, et al.. (1997). Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.. PubMed. 38(6). 1066–73. 11 indexed citations
6.
Chandler, Michael L., et al.. (1996). Ocular Toxicity of Ciprofloxacin/Pssa Fluoroquinolone Antibacterial Solution in Pigmented Rabbits. Journal of Toxicology Cutaneous and Ocular Toxicology. 15(2). 165–178. 1 indexed citations
7.
Tsin, Andrew, Brenda Walker Griffin, Nathan L. Mata, et al.. (1993). Vitamin A Homeostasis in the Diabetic Rat.. Journal of Clinical Biochemistry and Nutrition. 15(1). 23–31. 2 indexed citations
8.
Lou, Marjorie F., et al.. (1989). The Prevention of Biochemical Changes in Lens, Retina, and Nerve of Galactosemic Dogs by the Aldose Reductase Inhibitor AL01576. Journal of Ocular Pharmacology and Therapeutics. 5(3). 233–240. 13 indexed citations
9.
Griffin, Brenda Walker, et al.. (1987). Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats. Metabolism. 36(5). 486–490. 38 indexed citations
10.
Baker, J. L., Michael L. Chandler, Robert R. LeVier, & Ross Rudolph. (1981). Occurrence and Activity of Myofibroblasts in Human Capsular Tissue Surrounding Mammary Implants. Plastic & Reconstructive Surgery. 68(6). 913–914. 7 indexed citations
11.
Baker, James L., Michael L. Chandler, & Robert R. LeVier. (1981). Occurrence and Activity of Myofibroblasts in Human Capsular Tissue Surrounding Mammary Implants. Plastic & Reconstructive Surgery. 68(6). 905–912. 113 indexed citations
12.
Chandler, Michael L. & Partab T. Varandani. (1975). Insulin degradation. XIII. Kinetic analysis of the mechanism of insulin degradation by gluthathione-insulin transhydrogenase (thiol:protein-disulfide oxidoreductase). Biochemistry. 14(10). 2107–2115. 35 indexed citations
14.
Chandler, Michael L. & Partab T. Varandani. (1975). Insulin degradation. Biochimica et Biophysica Acta (BBA) - Enzymology. 397(2). 307–317. 13 indexed citations
15.
Chandler, Michael L. & Partab T. Varandani. (1974). Insulin Degradation: IX. On the Presence of Glutathione-insulin Transhydrogenase in Human Leukocytes. Diabetes. 23(3). 232–239. 9 indexed citations
16.
Chandler, Michael L. & Partab T. Varandani. (1973). Insulin degradation VIII. Protein thiols as co-substrates for glutathione- insulin transhydrogenase. Biochimica et Biophysica Acta (BBA) - General Subjects. 320(2). 258–266. 14 indexed citations
17.
Chandler, Michael L. & Partab T. Varandani. (1972). Insulin degradation. Biochimica et Biophysica Acta (BBA) - General Subjects. 286(1). 136–145. 48 indexed citations
18.
Chandler, Michael L. & Partab T. Varandani. (1972). Insulin degradation. II. The widespread distribution of glutathione-insulin transhydrogenase in the tissues of the rat.. PubMed. 286(1). 136–45. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026